Alnylam Pharmaceuticals Inc's late-stage trial data on its new gene silencing drug cast doubt on its safety, even as results revealed its effectiveness in treating a rare, painful disease.
from Reuters: Health https://ift.tt/2TwMec1
via IFTTT
Home
Health
Reuters: Health
Side effects of Alnylam's gene-silencing drug raise concerns, shares slip
0 comments: